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Abstract
Purpose The Auditory Vocal Hallucination Rating Scale Questionnaire (AVHRS-Q) is a short self-report measure assess-
ing several characteristics of auditory vocal hallucinations (AVH) that was derived from a validated clinical interview (the 
auditory vocal hallucination rating scale; AVHRS). This study investigated the internal reliability, convergent validity, and 
divergent validity of the AVHRS-Q using two clinical samples.
Methods In sample I, 32 psychiatric patients with AVH were recruited from an academic hospital service and assessed with 
the AVHRS and the AVHRS-Q. Data for sample II were retrospectively retrieved from a pseudonymised Routine Outcome 
Monitoring (ROM) database collected in the context of mental healthcare at the same academic hospital service. Data from 
82 psychiatric patients with AVH were retrieved, who completed the AVHRS-Q, and measures of psychological distress (the 
Outcome Questionnaire; OQ-45, and the Symptom Checklist; SCL-90) and quality of life (the Manchester Short Assessment 
of Quality of Life; MANSA).
Results The AVHRS-Q showed good internal consistency in both samples. Severity scores of the AVHRS-Q were strongly 
correlated to the severity scores of the AVHRS (r = 0.90, p < 0.01). The AVHRS-Q and AVHRS did not differ in the iden-
tification of mild and severe voice-hearers [X2 (1, N = 32) = 15.71]. AVHRS-Q severity scores had moderate correlations 
with measures of psychological distress (OQ-45, r = 0.43, p < 0.01; SCL-90, r = 0.50, p < 0.05) and quality of life (MANSA, 
r = − 0.22, p < 0.01).
Conclusions The AVHRS-Q demonstrated good reliability, convergent validity, and divergent validity, suggesting it can be 
applied in both clinical and research settings for a quick and reliable assessment of AVH.
Keywords Questionnaire · Validation study · Hallucinations · Psychosis
Introduction
Auditory vocal hallucinations (AVH) are prevalent in chil-
dren, adolescents, and adults, both in clinical settings and in 
the general population [1–4]. AVH are common in psychotic 
illnesses and other mental disorders such as depression, 
bipolar, dissociative, and substance use disorders [5]. AVH 
severity may be predictive of (amongst others) social prob-
lems [6, 7], suicidal ideation [8] or substance abuse [9] and 
a reliable assessment of AVH is therefore very important. 
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Given that voice-hearing is an internal experience which 
cannot be directly observed or measured, investigating AVH 
relies on the report of individual experiences. The most reli-
able manner to do this is using structured interviews and 
self-report instruments.
In 2012, Bartels-Velthuis and colleagues validated the 
AVHRS, a structured interview to gain insight into the char-
acteristics of voices [10] and from which a severity measure 
of voice-hearing can be derived. The AVHRS distinguishes 
itself from other measures for AVH, as besides the qualita-
tive characteristics and severity of AVH, it also assesses the 
form and content of voices (in contrast to the BAVQ-R; [11]) 
and the number of voices (in contrast to the PSYRATS; [12]) 
(see the validation paper [10] for a more elaborate descrip-
tion). Given that there has been a shift from interview meas-
ures to self-report measures of AVH [13], a questionnaire 
version of the AVHRS was warranted and has now been 
developed. Indeed, self-report measures have the benefit 
of being inexpensive and time-efficient and do not require 
training of assessors. This is especially useful when quick 
or frequent assessment of AVH is required. For example, in 
clinical practice this may be necessary for routine outcome 
monitoring (ROM) or for clinical intakes. Self-report meas-
ures may also be useful for research on clinical therapies, to 
examine to what extent or at which time-point, the occur-
rence, characteristics, and severity of AVH are changing.
A number of self-report measures for AVH are available 
[13]. These questionnaires are usually tailored to measure 
a specific aspect of AVH, for example beliefs about AVH 
(e.g., BAVQ-R; [11]), interpretations and attitudes towards 
AVH (e.g., VPD; [14]), coping with AVH (RAHQ; [15]), 
and mindfulness of AVH (SMVQ; [16]). There are some 
questionnaires on AVH that have a wider focus and are also 
quite brief (13 items, Hamilton Program for Schizophrenia 
Voices Questionnaire (HPSVQ), [17]; ten items, the delu-
sion and voices self-assessment (DV-SA), [18]). However, 
these questionnaires do not incorporate items on the form 
of address (1st, 2nd or 3rd person), the location of voices, 
separate or simultaneous voices, severity of negative con-
tent, or whether the voices make them anxious. The DV-SA 
specifically does not enquire about the duration or loudness 
of voices, or whether negative voices are present. Overall, 
compared to previous measures the AVHRS-Q ensures a 
comprehensive assessment of AVH, encompassing multiple 
qualitative aspects of AVH (e.g., negative voices, distress, 
interference with thinking and daily functioning) in a set of 
17 items.
The aim of this study is to validate a self-report version 
of the auditory vocal hallucination rating scale (AVHRS; 
[10, 19]), called the AVHRS-Q(uestionnaire). In this vali-
dation study, the internal consistency, convergent validity 
and divergent validity of the AVHRS-Q will be examined. 
It is expected that the AVHRS-Q will correlate highly with 
the interview version (AVHRS; [10]), demonstrating good 
convergent validity. As greater severity of AVH is related 
to both increased psychological distress and a lower quality 
of life [20], it is expected that the severity measure of the 
AVHRS-Q will correlate with measures of psychological 
distress (the outcome questionnaire, OQ-45; [21] and the 
symptom checklist, SCL-90; [22]) and quality of life (the 
Manchester Short Assessment of Quality of Life, MANSA; 
[23]). However, given that the AVHRS-Q specifically meas-
ures AVH characteristics and severity, and not general psy-
chological distress or quality of life, the correlations between 
these measures are expected to be no more than moderate, 
indicative of divergent validity.
Methods
Participants and procedures
For the current study data of two clinical samples (for 
demographics see Table 1) were used. Inclusion criteria 
consisted of receiving treatment for AVH, being between 
18 and 65 years old, and having a good command of the 
Table 1  Demographics of 
sample I and II
AVH auditory vocal hallucinations, N.A. not available
$ Psychotic disorders in these samples consisted of Schizophrenia, Schizoaffective disorder, and Psychotic 
disorder not otherwise specified
Sample I (n = 32) Sample II (n = 82)
Female (n, %) 18 (56) 44 (54)
Age (M, SD) 38 (11) 39 (12)
Duration of AVH in years (M, SD) 12 (11) N.A.
Psychotic  disorder$ (n, %) 29 (91) 60 (73)
 Also diagnosed with a comorbid disorder 8 (28) 24 (40)
Other disorder (e.g., mood disorder, personality disor-
der, anxiety disorder)
3 (9) 22 (27)
 Also diagnosed with a comorbid disorder 0 (0) 8 (36)
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Dutch language. Exclusion criteria consisted of having an 
organic brain disorder. Approval for the study with sample 
I was obtained from the Medical Ethics Committee of the 
University of Medical Center Groningen (ref: M13.146159). 
The sample size for sample I was calculated a priori by a 
statistician. It was determined that at least 31 people were 
required to obtain a two-sided confidence interval with 
minimum length of 0.1 for a correlation of 0.9. Thirty-two 
patients with AVH were recruited for sample I at the Voices 
Outpatient Department of the University Medical Center 
Groningen (The Netherlands). Patients were approached by 
their therapist or by the research coordinator of the Voices 
Outpatient Department, and received both verbal and writ-
ten information about the research study, including an 
informed consent form. Upon providing written informed 
consent, participants were contacted by the researcher and 
completed the AVHRS-Q and were interviewed with the 
AVHRS. During the study, participants alternately started 
with the self-report version of the AVHRS (AVHRS-Q) or 
with the interview (AVHRS) to rule out selective memory 
biases for one of the measurements. Data collection for sam-
ple I took place from February 2011 until December 2015.
Data for sample II were retrospectively retrieved from a 
pseudonymised routine outcome monitoring (ROM) data-
base collected in the context of mental healthcare at the 
Voices Outpatient Department of the University Medical 
Center Groningen (The Netherlands). All patients who are 
referred for treatment to the University Medical Center Gro-
ningen take part in ROM assessments and are informed that 
their data may be used for research purposes whilst having 
the option to opt-out. Given that these data were collected 
in the context of treatment and not for research purposes—
therefore not requiring the patient to change their behavior 
for the research—no additional ethical approval for the data 
is required according to Dutch legislation. Sample II con-
sisted of 82 patients with AVH receiving treatment at the 
Voices Outpatient Department of the University Medical 
Center Groningen (The Netherlands). At the start of their 
treatment, they completed the AVHRS-Q, the MANSA 
and either the OQ-45 (n = 62) and/or the SCL-90 (n = 24) 
(depending on which instrument their therapist selected) 
through the ROM service. The requested ROM data were 
collected from October 2011 until February 2017. As the 
current study took part in The Netherlands, all question-
naires and interviews were completed in Dutch language.
Measures
The AVHRS and development of the AVHRS-Q
The AVHRS [10, 19] is a structured 16-item interview, 
administered by an experienced therapist to evaluate AVH 
during a period of 1 month. The AVH are rated on four- and 
five-point scales in terms of frequency, duration, loudness, 
negative content, distress, anxiety, control, and interference 
with thinking and daily life. Scores range from 0 (not appli-
cable) to 3 or 4 (most applicable).
The AVHRS-Q [24] is the self-report version of the 
AVHRS, designed to be administered without the presence 
of an interviewer, therapist or researcher. A full version of 
the AVHRS-Q can be downloaded at https ://www.rgoc.nl/
downl oads (see Table 2 for a summary of the items). The 
AVHRS-Q has 17 items, 15 of which are assessed with 
a four- and five-point scale and two on a ten-point scale. 
For the four- and five-point scales, scores range from 0 
(not applicable) to 3 or 4 (most applicable). For the ten-
point scales, scores ranging from 1 (not at all/never) to 10 
(extremely/always). The items of the AVHRS-Q were based 
on the items of the AVHRS, but adapted somewhat for the 
purpose of self-report administration. The first version of the 
AVHRS-Q was evaluated by ten patients with AVH. Based 
on their feedback and input from experts in the field, ten 
questions from the original AVHRS were refined and one 
item was expanded into two items. To specify, some items of 
the AVHRS-Q received more answer options in comparison 
to the interview version (see Table 2, items 3, 4, 7, 8, 10, 
and 15). For example, the item assessing duration of voices 
has four answer options in the interview version (seconds, 
minutes, 1 h, and several hours to continuously) in compari-
son to five options in the questionnaire (see Table 2, item 
4). Moreover, the wording of some items was reformulated 
to be more simple and unambiguous (see Table 2, item 12 
and 13). Additionally, the AVH frequency and intensity of 
suffering in the AVHRS-Q (see Table 2, item 16 and 17) are 
rated on a ten-point scale instead of a five-point scale in the 
AVHRS, as to be more sensitive to subtle changes over time.
In accordance with the AVHRS and previous publica-
tions with this measure [4, 7, 25, 26], a severity index can be 
composed from the individual items of the AVHRS-Q. Items 
regarding the number of voices, localization of voices and 
hypnagogic/hypnopompic hallucinations are not included 
in the severity index (see previous publications; [10]). The 
answers to individual items are recoded to ‘0’ (none to mild 
consequences) or ‘1’ (considerable to severe consequences). 
Subsequently, a sum score of the recoded items is created, 
ranging from 0 to 14. In addition to the AVHRS-Q providing 
an overall severity measure of AVH, the individual items can 
also be used to yield specific information on characteristics 
of AVH (see Table 2).
Quality of life
Quality of life was assessed with the Manchester Short 
Assessment of Quality of Life (MANSA; [23]), a 16-item 
self-report measure consisting of four objective items and 
12 subjective items [satisfaction with life, accommodation, 
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Table 2  Summary of individual items of the AVHRS-Q and construction of the severity index
AVHRS-Q item Options Severity index (point 
awarded per option)
1. Number of voices Always one voice –
More than one voice
2. Separately or simultaneously Speaking separately 0
Speaking separately and together 1
Always speaking together 1
3. Frequency Not more than once a month 0
Once a week 0
Once a day 0
Once an hour 1
More than once an hour 1
4. Duration A few seconds 0
A few minutes 0
A few minutes to about 15 min 0
15 min to about an hour 1
One hour to almost constantly 1
5. Hypnagogic and/or hypnopompic voices Voices when falling asleep –
Voices when waking up
Voices both when falling asleep and when waking up
Voices occur at all times
6. Location Inside my head –
Inside my head and from the outside environment
From the outside environment (in the immediate vicinity)
From the outside environment, further away
7. Form of address The voices say what I am thinking (first person) 0
The voices speak to me (second person) 0
The voices speak to me and about me (second and third person) 1
The voices speak about me (third person) 1
8. Loudness Soft whisper or murmuring 0
More quiet than own voice 0
As loud as own voice 0
Louder than own voice 1
Much louder than own voice (yelling, shouting, and screaming) 1
9. Positive or negative content Always positive 0
Mostly positive but occasionally negative 0
Mostly neutral or equally positive and negative 0
Mostly negative 1
Always negative 1
10. Severity of negative content Negative, but not about myself or others 0
Negative about what I or others do 0
Negative about how I am or how others are 1
Threatening commands or orders 1
11. Anxiety Never 0
Occasionally 0
Half of the time 1
Most of the time 1
All of the time 1
12. Interference with daily functioning Never 0
Occasionally 0
Half of the time 0
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housemates (or living alone), leisure activities, physical 
health, psychological health, personal safety, friendships, 
relationship to family, (absence of) romantic relationship, 
sex life, and financial circumstances]. Items are rated on 
a seven-point Likert scale, ranging from 1 ‘could not be 
worse’ to 7 ‘could not be better’. The summary score con-
sists of the mean of the twelve subjective items, with higher 
scores indicating better quality of life.
Psychological distress
Psychological distress was assessed with either the outcome 
questionnaire (OQ-45) or the symptom checklist (SCL-90). 
Given that the data were collected through ROM assess-
ments for treatment purposes, the therapist was free to 
choose which assessment measure was administered to the 
patient on the basis of the therapists’ own preference and 
familiarity with the instrument. For the current study, both 
questionnaires were selected, as using only one would have 
led to a loss of information. The OQ-45 [21] is a 45-item 
self-report measure assessing clinical outcome in terms of 
symptom distress, interpersonal relations and social role 
performance. For this study, the symptom distress subscale 
was used consisting of 25 items. Each item is scored on a 
five-point rating scale, from never ‘0’ to almost always ‘4’. 
A sum score denoting psychological distress was computed 
by adding up all items, with high scores pointing to more 
distress. The SCL-90 [22] is a 90-item self-report meas-
ure, assessing a variety of psychopathology. Each item is 
rated on a five-point rating scale, from ‘1’ (never) to ‘5’ 
(almost always). The items are clustered in nine dimensions: 
somatization, obsessive–compulsive, interpersonal sensitiv-
ity, depression, anxiety, hostility, phobic anxiety, paranoid 
ideation, and psychoticism. A sum score denoting psycho-
logical distress was computed by adding up all items. Higher 
scores suggest a lower level of psychological and physical 
functioning.
Statistical analyses
Analyses were carried out using SPSS version 23 for Win-
dows [27]. In sample I, two severity groups were created 
Table 2  (continued)
AVHRS-Q item Options Severity index (point 
awarded per option)
Most of the time 1
All of the time 1
13. Interference with thoughts Never 0
Occasionally 0
Half of the time 1
Most of the time 1
All of the time 1
14. Control Always 0
Most of the time 0
Half of the time 0
Less than half of the time 1
Never 1
15. Attribution of origin The voices only concern myself 0
The voices mostly concern myself 0
Equally concern myself as outside influences 1
Mostly caused by outside influences 1
Fully caused by outside influences 1








Total Minimum = 0
Maximum = 14
This table represents a summary of the questionnaire and should not be used for administration. The full questionnaire can be downloaded at: 
https ://www.rgoc.nl/downl oads
AVHRS-Q auditory vocal hallucination rating scale questionnaire
932 Social Psychiatry and Psychiatric Epidemiology (2019) 54:927–935
1 3
separately for both the AVHRS and AVHRS-Q: those with 
‘severe AVH’ (scoring in the highest quartile of the severity 
index, i.e., in our study 10 or higher) and with ‘mild AVH’ 
(scoring 0–9).
To examine convergent validity in sample I, Pearson 
correlation coefficients between total severity scores and 
separate items of the AVHRS and AVHRS-Q were com-
puted. A paired-samples t test was performed to examine 
the differences in the mean AVH severity score between the 
AVHRS-Q and the AVHRS. An exact McNemar’s test was 
used to examine the distribution of mild and severe AVH 
groups between the two measures. Internal consistency of 
both instruments was determined by calculating Cronbach’s 
alpha [28].
To examine divergent validity in sample II, Pearson cor-
relation coefficients between the total severity score of the 




In sample I, the AVHRS-Q took an average of 5.8 min to 
be completed (SD: 2.72, range: 2–15), whereas the AVHRS 
took an average of 14.3 min to administer (SD: 4.69, range: 
8.3–27).
Internal consistency
In sample I, Cronbach’s alpha of both the AVHRS-Q and 
the AVHRS was 0.87. In sample II, Cronbach’s alpha of the 
AVHRS-Q amounted to 0.78.
Convergent validity
The average severity scores and severity groups for both the 
AVHRS-Q and AVHRS for sample I are given in Table 3. 
The severity measures of the AVHRS and AVHRS-Q 
were highly correlated. This correlation did not differ for 
participants who started with the AVHRS (r = 0.90, p < 0.01) 
and those who started with the AVHRS-Q (r = 0.89, 
p < 0.01). The Pearson correlation coefficients between indi-
vidual corresponding items of both measures ranged from 
0.44 (moderate) to 0.82 (high), with a median of 0.72 (see 
Table 4). The mean AVH severity measure and the distribu-
tion of severity groups did not differ significantly between 
the AVHRS-Q and the AVHRS.
Table 3  Average AVH 
severity score and distribution 
of severity groups for the 
AVHRS-Q and AVHRS (sample 
I, N = 32)
AVH auditory vocal hallucinations, AVHRS-Q auditory vocal hallucination rating scale questionnaire, 
AVHRS auditory vocal hallucination rating scale
*p < 0.05, **p < 0.01




6.91 (3.15) 7.38 (3.66) r = 0.90** t(31) = −0.55
AVH severity group (N, %)
 Mild 24 (75%) 22 (68.8%) X2 (1, N = 32) = 15.71
 Severe 8 (25%) 10 (31.3%)
Table 4  Correlations between individual items of the AVHRS-Q and 
AVHRS
AVHRS-Q auditory vocal hallucination rating scale questionnaire, 
AVHRS auditory vocal hallucination scale
*p < 0.05, **p < 0.01
$ Could not be computed as all participants consistently reported 
option 4 (at all times of the day)
AVHRS-Q item Pearson correlation with 
corresponding item on 
AVHRS
1. Number of voices 0.86**
2. Separately or simultaneously 0.84**
3. Frequency 0.73**
4. Duration 0.70**
5. Hypnagogic and/or hypnopompic 
 voices$
6. Location 0.71**
7. Form of address 0.56**
8. Loudness 0.78**
9. Positive or negative content 0.85**
10. Severity of negative content 0.57**
11. Anxiety 0.74**
12. Interference with daily functioning 0.46**
13. Interference with thoughts 0.52**
14. Control 0.82**
15. Attribution of origin 0.84**
16. Frequency of distress 0.44*
17. Intensity of distress 0.70**
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Divergent validity
Descriptives of sample II are given in Table 5. In sample 
II, the AVHRS-Q severity score was moderately correlated 
with the psychological distress (OQ-45 and SCL-90) and 
the quality of life (MANSA) scores. AVH severity was not 
significantly different between those who did and did not 
complete the OQ-45 [t(80) = 0.46, p > 0.05] and SCL-90 
[t(80) = − 0.48, p > 0.05].
Discussion
The current study shows that the auditory vocal hallucina-
tion rating scale questionnaire (AVHRS-Q) [24] is a reliable 
and valid self-report instrument to assess the characteristics 
and severity of auditory vocal hallucinations (AVH). The 
findings demonstrate that the AVHRS-Q converges highly 
with the interview measure on which it was based  (the 
AVHRS; [10]). In addition, the AVHRS-Q is shown to be 
a specific measure of AVH and not a general measure of 
psychological distress (OQ-45; [21] and SCL-90; [22]) or 
quality of life (MANSA; [23]). Internal reliability of the 
AVHRS-Q was found to be good and comparable to the reli-
ability of the AVHRS.
The AVHRS-Q severity scores correlate highly with 
the corresponding severity scores of the interview version 
(AVHRS). In addition, the AVHRS-Q and the AVHRS did 
not identify a different proportion of patients as having 
‘mild’ or ‘severe’ AVH. This implies that the already vali-
dated and widely used AVHRS [10, 29–31] can now also 
be used in the self-report version for the same (research 
or clinical) purposes. Importantly, the individual items of 
the AVHRS-Q also corresponded highly to the items of the 
AVHRS, with the exception of four moderately correlating 
items. Given that the AVHRS-Q had to be short and not 
(too) cognitively demanding, explanations, and examples 
of items were not included in the self-report questionnaire. 
This may have resulted in discrepancies (and therefore 
moderate correlations) between four specific items of the 
AVHRS-Q and AVHRS. It is therefore important to keep 
in mind that whilst the AVHRS-Q can be used to reliably 
achieve a quick overall severity measure of AVH (similar to 
the interview-based AVHRS), one should be cautious when 
only interpreting single items of the AVHRS-Q (specifi-
cally the items on form of address, severity of negative con-
tent, interference with daily functioning, interference with 
thoughts). Moreover, the AVHRS-Q severity scores were 
only moderately related to measures of quality of life and 
psychological distress, which indicates that the AVHRS-Q 
specifically measures characteristics and severity of AVH. 
Overall, the AVHRS-Q demonstrates good convergent and 
divergent validity in this study.
An important feature of the AVHRS-Q is that it takes 
only 6 min on average to complete. This makes it excep-
tionally suitable for quick and frequent assessments, for 
instance in research on the effectiveness of treatments or 
for frequent monitoring in a clinical context, such as rou-
tine outcome monitoring (ROM) assessments. Currently, 
ROM assessments for patients with psychosis often consist 
of more global outcome measures for positive symptoms, 
such as the positive and negative syndrome scale (PANSS) 
[32–34]. One PANSS item assesses the severity of halluci-
nations, but does not inquire about, for example, whether 
the patient has separate or simultaneous voices, whether the 
patient has negative or positive voices, or even how AVH 
interfere with daily functioning. All these aspects may be 
potentially relevant for treatment or in signifying the nature 
of distress. Currently, the AVHRS-Q is being utilized in the 
ROM protocol of the Voices Outpatient Department of the 
University Medical Center Groningen.
The current study has some limitations. First, in contrast 
to the HPSVQ [17] and the DV-SA [18], the AVHRS-Q 
does not enquire about the social circumstances of AVH, or 
whether the command hallucinations are obeyed. However, 
the AVHRS-Q does enquire about the interference with daily 
functioning and the presence of command hallucinations, 
which can be further explored during therapy. Second, simi-
lar to the validation study on the AVHRS interview [10] we 
did not measure sensitivity to change. As all patients were 
in therapy for their voices and the AVHRS-Q is incorporated 
in treatment, retest data would likely be confounded with 
therapeutic effects. To assess this in an unbiased manner, a 
control group not receiving treatment for their AVH should 
have been included. However, given that all patients had 
quite severe AVH for a substantial amount of years, this 
was deemed unethical. Third, the current study recruited 
two reasonably chronic patient samples, implying the current 
findings may be less generalizable to healthier populations. 
However, the AVHRS-Q has already been administered in a 
general population sample, supporting its use in less chronic 
samples [25].
Table 5  Comparison of average AVH severity scores (AVHRS-Q) 
with measures of quality of life (MANSA) and psychological distress 
(OQ-45 and SCL-90) (sample II)
AVH auditory vocal hallucinations, AVHRS-Q auditory vocal halluci-
nation rating scale questionnaire, AVHRS auditory vocal hallucination 
rating scale, MANSA the manchester short assessment of quality of 
life, SCL-90 symptom checklist, OQ-45 outcome questionnaire







AVH severity score 
(Pearson’s r)
7.66 (2.69) − 0.22** 0.50* 0.43**
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One important strength of the current study is that the 
AVHRS-Q is based on an existing measure, the AVHRS, 
which has already been deemed to have good psychomet-
ric properties [10] and was used in multiple research pro-
jects [26, 30]. A second strength is that the AVHRS-Q was 
evaluated by patients with AVH and that their feedback was 
used to improve the AVHRS-Q into its current form. Third, 
given that AVH are prevalent in multiple disorders, there-
fore, being a trans-diagnostic symptom, it is a strength that 
the AVHRS-Q was tested in patients with different disorders.
To conclude, the AVHRS-Q is a quick self-report version 
of a validated interview on auditory hallucinations already 
in use, the AVHRS. The current study demonstrates that the 
AVHRS-Q has good internal consistency, convergent valid-
ity and divergent validity. The AVHRS-Q can very well be 
applied in both clinical practice and research, where it is 
required to assess AVH in a quick and reliable manner.
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